Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Palles C.,,Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas,2013,Nature Genetics,554,10.1038/ng.2503,United Kingdom,Article,Oxford,0,Journal,2-s2.0-84873096362
Siegel R.,,"Cancer statistics, 2013",2013,CA Cancer Journal for Clinicians,10747,10.3322/caac.21166,United States,Article,Atlanta,1,Journal,2-s2.0-84872967522
Le Gallo M.,,Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes,2012,Nature Genetics,256,10.1038/ng.2455,United States,Article,Bethesda,0,Journal,2-s2.0-84870532434
Koboldt D.C.,,Comprehensive molecular portraits of human breast tumours,2012,Nature,6015,10.1038/nature11412,United States,Article,St. Louis,1,Journal,2-s2.0-84877028141
Kuhn E.,,Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses,2012,Journal of the National Cancer Institute,149,10.1093/jnci/djs345,United States,Article,Baltimore,1,Journal,2-s2.0-84867324518
Govindan R.,,Genomic landscape of non-small cell lung cancer in smokers and never-smokers,2012,Cell,747,10.1016/j.cell.2012.08.024,United States,Article,St. Louis,1,Journal,2-s2.0-84866434919
McConechy M.,,Use of mutation profiles to refine the classification of endometrial carcinomas,2012,Journal of Pathology,191,10.1002/path.4056,Canada,Review,Vancouver,0,Journal,2-s2.0-84864764430
Cowin P.,,LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin,2012,Cancer Research,59,10.1158/0008-5472.CAN-12-0203,Australia;Australia,Article,Melbourne;Parkville,1,Journal,2-s2.0-84865137809
Muzny D.M.,,Comprehensive molecular characterization of human colon and rectal cancer,2012,Nature,4331,10.1038/nature11252,United States,Article,Houston,1,Journal,2-s2.0-84863922124
Byron S.,,"Fgfr2 point mutations in 466 endometrioid endometrial tumors: Relationship with msi, kras, pik3ca, ctnnb1 mutations and clinicopathological features",2012,PLoS ONE,105,10.1371/journal.pone.0030801,United States,Article,Phoenix,1,Journal,2-s2.0-84857549430
Ciriello G.,,Mutual exclusivity analysis identifies oncogenic network modules,2012,Genome Research,368,10.1101/gr.125567.111,United States,Article,New York,1,Journal,2-s2.0-84856535081
Hinoue T.,,Genome-scale analysis of aberrant DNA methylation in colorectal cancer,2012,Genome Research,429,10.1101/gr.117523.110,United States,Article,Los Angeles,1,Journal,2-s2.0-84856549042
Bartosch C.,,Endometrial carcinomas: A review emphasizing overlapping and distinctive morphological and immunohistochemical features,2011,Advances in Anatomic Pathology,62,10.1097/PAP.0b013e318234ab18,Portugal,Review,Porto,0,Journal,2-s2.0-80054700582
Bell D.,,Integrated genomic analyses of ovarian carcinoma,2011,Nature,4070,10.1038/nature10166,United States,Article,Rochester,1,Journal,2-s2.0-79959838081
Urick M.E.,,PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer,2011,Cancer Research,134,10.1158/0008-5472.CAN-11-0549,United States,Article,Bethesda,1,Journal,2-s2.0-79958820962
Cheung L.W.T.,,High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability,2011,Cancer Discovery,281,10.1158/2159-8290.CD-11-0039,United States,Article,Houston,1,Journal,2-s2.0-80054778946
Mermel C.,,GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers,2011,Genome Biology,1010,10.1186/gb-2011-12-4-r41,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-79955166265
Gaujoux R.,,A flexible R package for nonnegative matrix factorization,2010,BMC Bioinformatics,385,10.1186/1471-2105-11-367,South Africa,Article,Cape Town,1,Journal,2-s2.0-77954069195
Vaske C.,,Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM,2010,Bioinformatics,429,10.1093/bioinformatics/btq182,United States,Article,Santa Cruz,1,Journal,2-s2.0-77954195272
Noushmehr H.,,Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma,2010,Cancer Cell,1466,10.1016/j.ccr.2010.03.017,United States,Article,Los Angeles,1,Journal,2-s2.0-77952108366
Clarke B.,,Endometrial carcinoma: Controversies in histopathological assessment of grade and tumour cell type,2010,Journal of Clinical Pathology,68,10.1136/jcp.2009.071225,Canada,Review,Toronto,0,Journal,2-s2.0-77951664346
Pleasance E.,,A comprehensive catalogue of somatic mutations from a human cancer genome,2010,Nature,1163,10.1038/nature08658,United Kingdom,Article,Hinxton,1,Journal,2-s2.0-74449093973
Fleming G.,,"Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study",2010,Gynecologic Oncology,194,10.1016/j.ygyno.2009.09.025,United States,Article,Chicago,0,Journal,2-s2.0-70749097152
Shen R.,,Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis,2009,Bioinformatics,296,10.1093/bioinformatics/btp543,United States,Article,New York,1,Journal,2-s2.0-70449331456
Yemelyanova A.,,Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: Immunohistochemical analysis of 201 cases,2009,American Journal of Surgical Pathology,118,10.1097/PAS.0b013e3181ac35f5,United States,Article,Baltimore,0,Journal,2-s2.0-70349695904
Salvesen H.B.,,Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation,2009,Proceedings of the National Academy of Sciences of the United States of America,219,10.1073/pnas.0806514106,Norway;Norway,Article,Bergen;Bergen,1,Journal,2-s2.0-63849308483
Houseman E.,,Model-based clustering of DNA methylation array data: A recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions,2008,BMC Bioinformatics,134,10.1186/1471-2105-9-365,United States;United States,Article,Boston;Providence,1,Journal,2-s2.0-52949118548
Sinner D.,,Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells,2007,Molecular and Cellular Biology,226,10.1128/MCB.02179-06,United States,Article,Cincinnati,1,Journal,2-s2.0-36048993973
Pollock P.,,Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes,2007,Oncogene,221,10.1038/sj.onc.1210529,United States,Article,Phoenix,1,Journal,2-s2.0-34250829395
Zighelboim I.,,Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type,2007,Journal of Clinical Oncology,139,10.1200/JCO.2006.08.2107,United States,Article,St. Louis,0,Journal,2-s2.0-34249949422
Sutton G.,,Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: A Gynecologic Oncology Group study,2005,Gynecologic Oncology,90,10.1016/j.ygyno.2005.03.011,United States,Article,Indianapolis,0,Journal,2-s2.0-20444461501
Li J.,,Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3β,2005,Gastroenterology,78,10.1053/j.gastro.2005.02.067,United States,Article,Boston,0,Journal,2-s2.0-20444449617
Fleming G.,,Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study,2004,Journal of Clinical Oncology,451,10.1200/JCO.2004.07.184,United States,Article,Chicago,0,Journal,2-s2.0-2942657617
Brunet J.,,Metagenes and molecular pattern discovery using matrix factorization,2004,Proceedings of the National Academy of Sciences of the United States of America,994,10.1073/pnas.0308531101,United States,Article,Cambridge,1,Journal,2-s2.0-1642529511
Toyota M.,,CpG island methylator phenotype in colorectal cancer,1999,Proceedings of the National Academy of Sciences of the United States of America,1945,10.1073/pnas.96.15.8681,United States,Article,Baltimore,1,Journal,2-s2.0-0033587747
Zorn A.,,Regulation of Wnt signaling by Sox proteins: XSox17α/β and XSox3 physically interact with β-catenin,1999,Molecular Cell,291,10.1016/S1097-2765(00)80200-2,United States,Article,Cambridge,1,Journal,2-s2.0-0033213619
Levine R.,,"PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma",1998,Cancer Research,217,,United States,Article,Baltimore,0,Journal,2-s2.0-0032146038
Lax S.,,A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.,1997,Verhandlungen der Deutschen Gesellschaft für Pathologie,127,,United States,Review,Baltimore,0,Journal,2-s2.0-0031297547
Hockenbery D.,,Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death,1990,Nature,3431,10.1038/348334a0,United States,Article,St. Louis,0,Journal,2-s2.0-0025204548
